{rfName}
TR

Indexat a

Llicència i ús

Citacions

Altmetrics

Anàlisi d'autories institucional

Llimós-Aubach JAutor o coautorPujol-Coma AAutor o coautorCastellanos AAutor o coautorBahamonde MiAutor o coautorComes NAutor o coautorCallejo GAutor o coautorGasull XAutor o coautor
Compartir
Publicacions
>
Article pendent de publicació

TRESK background potassium channel regulates MrgprA3 + pruriceptor excitability, acute and chronic itch.

Publicat a:Pain. - 2025-03-06 (), DOI: 10.1097/j.pain.0000000000003540

Autors: Llimós-Aubach J; Andres-Bilbe A; Pujol-Coma A; Castellanos A; Pallás I; Bahamonde MI; de Anta JM; Soler C; Comes N; Callejo G; Gasull X

Afiliacions

Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona, Barcelona, Spain. - Autor o coautor
Neurophysiology Laboratory, Department of Biomedicine, Medical School, Institute of Neurosciences, Universitat de Barcelona, Barcelona, Spain. - Autor o coautor

Resum

A subset of peripheral sensory neurons expressing specific Mas-related G-protein-coupled receptors and transient receptor potential channels mediate pruritogen-induced chemical itch. However, the molecular mechanisms that regulate the excitability of these cells, and consequently itch sensation, are poorly understood. TWIK-related spinal cord K + channel (TRESK) is a background K + channel that modulates the resting membrane potential, action potential firing, and neuronal excitability, and it has been involved in somatosensation and pain transduction. Here, we demonstrate that this channel contributes to pruritic transduction and it is a potential target for treating chronic itch pathologies. TRESK channel coexpress with Mas-related G-protein-coupled receptor A3, MrgprC11 and MrgprD in mouse sensory neurons, and with MrgprX1 in human ones. Genetic ablation of TRESK enhances firing of MrgprA3-expressing pruriceptors and acute itch in response to intradermal injection of chloroquine, while the response to histamine, BAM8-22, or leukotriene C4 remains unaffected. TRESK deletion also exacerbates chronic itch in mouse models of allergic contact dermatitis, dry skin, and imiquimod-induced psoriasiform dermatitis, resulting in a significantly increased scratching behavior that develops earlier and is more robust. Moreover, pharmacologically enhancing TRESK function diminishes both acute and chronic itch in wild-type mice but not in TRESK knockout (KO) animals. In summary, our data indicate that TRESK plays a role in regulating the excitability of a subset of sensory neurons that mediate histaminergic-independent itch. Enhancing the channel function with specific activators represents a promising antipruritic therapeutic approach that can be combined with other compounds for the treatment of nonhistaminergic itch, which currently lack adequate treatment options.

Paraules clau
AnesthesiologyAnesthesiology and pain medicineBiotecnologíaCiências biológicas iCiências biológicas iiCiências biológicas iiiCiencias socialesClinical neurologyEducação físicaEnfermagemFarmaciaGeneral medicineInterdisciplinarMedicina iMedicina iiMedicina iiiMedicine (all)NeurologyNeurology (clinical)NeurosciencesOdontologíaPharmacologyPsicologíaPsychologySaúde coletiva

Indicis de qualitat

Impacte bibliomètric. Anàlisi de la contribució i canal de difusió

El treball ha estat publicat a la revista Pain a causa de la seva progressió i el bon impacte que ha aconseguit en els últims anys, segons l'agència WoS (JCR), s'ha convertit en una referència en el seu camp. A l'any de publicació del treball, 2025, es trobava a la posició 34/310, aconseguint així situar-se com a revista Q1 (Primer Cuartil), en la categoria Neurosciences.

Anàlisi del lideratge dels autors institucionals

Hi ha un lideratge significatiu, ja que alguns dels autors pertanyents a la institució apareixen com a primer o últim signant, es pot apreciar en el detall: Primer Autor (Llimós Aubach, Júlia) i Últim Autor (Gasull Casanova, Xavier).